Page last updated: 2024-10-16

quinacrine and Carcinogenesis

quinacrine has been researched along with Carcinogenesis in 1 studies

Quinacrine: An acridine derivative formerly widely used as an antimalarial but superseded by chloroquine in recent years. It has also been used as an anthelmintic and in the treatment of giardiasis and malignant effusions. It is used in cell biological experiments as an inhibitor of phospholipase A2.
quinacrine : A member of the class of acridines that is acridine substituted by a chloro group at position 6, a methoxy group at position 2 and a [5-(diethylamino)pentan-2-yl]nitrilo group at position 9.

Carcinogenesis: The origin, production or development of cancer through genotypic and phenotypic changes which upset the normal balance between cell proliferation and cell death. Carcinogenesis generally requires a constellation of steps, which may occur quickly or over a period of many years.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khurana, A1
Roy, D1
Kalogera, E1
Mondal, S1
Wen, X1
He, X1
Dowdy, S1
Shridhar, V1

Other Studies

1 other study available for quinacrine and Carcinogenesis

ArticleYear
Quinacrine promotes autophagic cell death and chemosensitivity in ovarian cancer and attenuates tumor growth.
    Oncotarget, 2015, Nov-03, Volume: 6, Issue:34

    Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Carcinogenesis; Cell Death; Cell Line, Tumor;

2015